key: cord-0986301-5h4muevf
authors: Niu, Yuanyuan; Zhan, Zan; Li, Jianfeng; Shui, Wei; Wang, Changfeng; Xing, Yanli; Zhang, Changran
title: Development of a Predictive Model for Mortality in Hospitalized Patients With COVID-19
date: 2021-01-08
journal: Disaster medicine and public health preparedness
DOI: 10.1017/dmp.2021.8
sha: da39d134958aa05c823fa1612357b70e02e8d21f
doc_id: 986301
cord_uid: 5h4muevf

INTRODUCTION: Early identification of patients with novel corona virus disease 2019 (COVID-19) who may be at high mortality risk is of great importance. METHODS: In this retrospective study, we included all patients with COVID-19 at Huanggang Central Hospital from January 23 to March 5, 2020. Data on clinical characteristics and outcomes were compared between survivors and nonsurvivors. Univariable and multivariable logistic regression were used to explore risk factors associated with in-hospital death. A nomogram was established based on the risk factors selected by multivariable analysis. RESULTS: A total of 150 patients were enrolled, including 31 nonsurvivors and 119 survivors. The multivariable logistic analysis indicated that increasing the odds of in-hospital death associated with higher Sequential Organ Failure Assessment score (odds ratio [OR], 3.077; 95% confidence interval [CI]: 1.848-5.122; P < 0.001), diabetes (OR, 10.474; 95% CI: 1.554-70.617; P = 0.016), and lactate dehydrogenase greater than 245 U/L (OR, 13.169; 95% CI: 2.934-59.105; P = 0.001) on admission. A nomogram was established based on the results of the multivariable analysis. The AUC of the nomogram was 0.970 (95% CI: 0.947-0.992), showing good accuracy in predicting the risk of in-hospital death. CONCLUSIONS: This finding would facilitate the early identification of patients with COVID-19 who have a high-risk for fatal outcome.

enrolled 150 patients with COVID-19 were obtained from electronic medical records. Test results at baseline rather than the worst value during hospitalization were used to predict clinical outcome. A team of experienced respiratory clinicians reviewed, abstracted, and cross-checked the data.

Throat-swab samples were obtained from all patients on admission and tested for the presence of SARS-CoV-2 infection by using realtime reverse transcriptase-polymerase chain reaction assays (RT-PCR) according to a previously described protocol. 7 Throat-swab specimens were obtained for RT-PCR re-examination every 2 to 3 d. For patients with repeated PCR tests, the first date of the result was recorded if the patients had consecutive negative results, while the latest result and date were recorded for patients who had inconsistent results of the consecutive tests.

The criteria for discharge were absence of fever for at least 7 d, basically normal blood oxygen saturation without supplemental oxygen, substantial improvement in chest CT scans, and 2 consecutive throat-swab samples negative for SARS-CoV-2 RT-PCR test taken at least 24 h apart.

Fever was defined as axillary temperature of at least 37.3°C. Sepsis and septic shock were defined according to the 2016 Third International Consensus Definition for Sepsis and Septic Shock. 8 Acute kidney injury (AKI) was diagnosed according to the Kidney Disease Improving Global Guidelines (KDIGO). 9 ARDS was diagnosed according to the Berlin Definition. 10 Acute cardiac injury was diagnosed if the serum levels of cardiac biomarkers (eg, cardiac troponin I) were above the 99th percentile upper reference limit or if new abnormalities were shown in electrocardiography and echocardiography. 7 The illness severity of COVID-19 was defined according to the Chinese management guideline for COVID-19 (version 6.0). 11 Coagulopathy was defined as a 3-s extension of prothrombin time or a 5-s extension of activated partial thromboplastin time. Hypoproteinemia was defined as blood albumin of less than 25 g/L. Exposure history was defined as exposure to people with confirmed SARS-CoV-2 infection or residence or travel history in Wuhan in the last month, especially in the last 2 wk. The worldwide accepted pneumonia severity scoring systems such as CURB-65.12] and Pneumonia Severity Index (PSI) 13 ] were used to assess pneumonia severity. Critical illness evaluation systems, including Sequential Organ Failure Assessment (SOFA) 14 ] and Acute Physiology and Chronic Health Evaluation II (APACHE II), 15 were used to assess disease severity.

Categorical variables were presented as numbers (percentages) and analyzed using χ2 test or Fisher's exact test. Continuous variables with skewed distribution were shown as median (interquartile ranges) and analyzed using Mann-Whitney U test. If the missingness of continuous variables did not exceed 30%, the median was used to fill in. The variables, including baseline characteristics, laboratory findings, were excluded those with more than 30% missing values and unconfirmed indicators (eg, exposure, which was self-reported). Logistic regression was used for univariable and multivariable analyses to explore the risk factors associated with in-hospital death. Variables with P value <0.1 entered into logistic multivariable analysis. Continuous variables were dichotomized. It was determined that whether or not with multicollinearity among independent variables. Forward-stepwise regression was used to select variables. Area under curve (AUC), sensitivity, and specificity were analyzed using the receiver operating characteristic curve (ROC). A nomogram was established based on the results of multivariable analysis. The C-index, decision curve, and clinical impact curve were used to verify the nomogram. A 2-sided P < 0.05 was considered statistically significant. All statistical analyses were performed using SPSS (version 25.0), R program (version 3.5.1), and Graphpad Prism (version 8.0).

A total of 150 patients were enrolled in this study, including 31 dead patients and 119 discharged patients. As shown in Table 1 , the nonsurvivors were older than the survivors (73 [IQR 62-79] y vs 48 [IQR 37-57]) y, P < 0.001). There were more male nonsurvivors (61.3%), while the survivors were dominated by females (58.0%). We noted that more nonsurvivors had hypertension, cardiovascular diseases, and cerebrovascular diseases than the survivors. The most common symptoms on admission were fever and cough, followed by fatigue. Dyspnea was more common in the nonsurvivors. Approximately one-third of the patients had a definite history of exposure before illness onset, and the median time from exposure to illness onset was 5.5 (IQR 4.8-10) d. General patients (83.2%) accounted for the majority in the survivor group, while severe and critical patients accounted for 93.5% in the nonsurvivor group. In addition, the nonsurvivors had higher CURB-65, PSI, SOFA, and APACHE II scores ( Figure 1 ).

Laboratory findings on hospital admission are summarized in Table 2 . White blood cell counts and neutrophil counts were elevated, while lymphocyte counts and platelet counts were decreased in the nonsurvivor group compared with those in the survivor group. The nonsurvivors showed higher levels of total bilirubin, blood ureanitrogen (BUN), creatinine, fasting blood glucose, lactate dehydrogenase (LDH), and D-dimer, but lower albumin levels than the survivors. C-Reactive protein and procalcitonin (PCT) were also different between the nonsurvivors and survivors.

During the period from admission to death, laboratory indicators showed a dynamic change in the nonsurvivors, especially in the levels of lymphocyte counts, LDH, BUN, and D-dimer ( Figure 2 ). The serial biomarker results were based on a very small subcohort because most patients were not continuously monitored during hospitalization.

The most common imaging features were ground glass opacification (86.0%) and bilateral pulmonary infiltration (82.7%). Pleural effusion (22.6% vs 2.5%, P < 0.001) occurred more frequently in the nonsurvivors.

As shown in Table 3 , of the 150 patients, sepsis was the most frequently observed complication (37.3%), followed by respiratory failure (26.7%). All of the nonsurvivors experienced sepsis. The common complications of the nonsurvivors included respiratory failure (93.5%), ARDS (83.9%), coagulopathy (77.4%), acidosis P < 0.001), even the virus was continuously detectable until death in 17 nonsurvivors.

On the univariable analysis, the risk factors associated with in-hospital death were age, hypertension, diabetes, and cardiovascular disease. The elevated respiratory rate, PSI score, SOFA score, APACHE II score, white blood cell counts, total bilirubin, BUN, creatinine, LDH, D-dimer, and the decreased white blood cell counts, lymphocyte counts, platelet counts, and albumin were also associated with in-hospital death ( Table 4) 

The independent predictors were used to establish a nomogram, and the points of each variable are shown in Figure 3A . The ROC curve analysis revealed that the AUC of the nomogram was 0.970 (95% CI: 0.947-0.992), showing good accuracy in predicting the risk of in-hospital death ( Figure 3B ). The sensitivity was 90.3%, and the specificity was 90.8%. The favorable calibration curve indicated that the prediction by the nomogram was highly consistent with the actual observation ( Figure 3C ). Moreover, the clinical impact curve ( Figure 3D ) indicated that the nomogram had good net benefits for the identification of the fatal outcome of patients with COVID-19.

Fifty-two of 512 hospitalized patients with COVID-19 between March 5, 2020, and May 1, 2020, including all 12 dead patients and 40 discharged patients who were randomly selected according to hospitalization number, were enrolled to perform an external validation. The AUC of the nomogram was 0.923 (95% CI: 0.828-1.000), and the predictive accuracy was 0.942. The model was confirmed to be reliable.

Most of patients with COVID-19 present with mild flu-like symptoms and recover quickly. However, many severe patients show rapid progression and develop multiple organ dysfunction, even death, indicating that recognition of risk factors are essential to identify those potentially needing critical care and management at an early stage. Several studies focused on risk factors associated with poor prognosis, including elder age, comorbidities, lymphopenia, D-dimer greater than 1 μg/L, elevated CRP, high LDH, high hypersensitive troponin I, high interleukin-6, hyperglycemia, and hypoproteinemia. However, these clinical and laboratory indicators are independent, 2,5,16-18 which cannot comprehensively reflect the prognosis of COVID-19.

To our knowledge, no mature and reliable scoring system has been established to assess the risk of death in hospital with COVID-19. SOFA score is a low-cost, 2-min bedside clinical tool introduced to facilitate early recognition of sepsis and multi-organ dysfunction. SOFA score is a consistent and convincing tool that can be used across different patient populations and clinical settings. In the current study, we determined that sepsis occurred in 37.3% of patients with COVID-19 due to viral infection. We also identified SOFA score as an independent risk factor for death in adults who were hospitalized due to COVID-19.

Reports from the Chinese Center for Disease Control and Prevention from 44,672 confirmed cases of COVID-19 showed that patients with diabetes had a 3-fold higher overall case-fatality rate than those without diabetes (7.3% vs 2.3%, respectively). 19 According to our results, we believed that increasing odds of death in hospital was associated with history of diabetes. The elevated LDH was confirmed as a predictive biomarker of death, consistent with those in previous reports. 16, 20 Furthermore, our study developed a nomogram model based on risk factors selected by multivariable logistic regression analysis to accurately predict fatal outcomes of patients with COVID-19. The nomogram model performed well in predicting in-hospital death, supported by external validation.

Few studies reported the long shedding of SARS-CoV-2 RNA, especially in severe patients. 2, 21 Among male patients, delayed admission to hospital after illness onset, and invasive mechanical ventilation were associated with prolonged SARS-CoV-2 RNA shedding. 22 In the current study, we found that the duration of SARS-CoV-2 viral shedding had median values of 6 d in the survivor group and 12 d in the nonsurvivor group; 17 patients were Procalcitonin, ng/mL, n (%) § <0. 

nucleic acid positive until death. Although most studies have used qualitative or quantitative PCR tests as a diagnostic marker for infectious SARS-CoV-2, caution is required when applying such data to assess the duration of viral shedding and infection potential because PCR does not distinguish between infectious virus and noninfectious nucleic acid.

COVID-19 mainly injures the respiratory system, and some patients rapidly progress to ARDS. We found that the incidence of ARDS was 17.3%, and the median time from illness onset to ARDS was 10.5 (IQR, [9] [10] [11] [12] d, consistent with previous reports. 2, 23 At present, the mechanisms of COVID-19-related ARDS remain unclear. The entry of pathogenic SARS-CoV-2 in humans leads to the activation of inflammatory cells, specifically CD4 lymphocytes, which subsequently transform into T helper 1 (Th1) cells. Activated inflammatory cells (Th1 cells and macrophages) enter the pulmonary circulation and induce cytokines (ie, "cytokine storm"), which lead to rapid and widespread damage of the pulmonary epithelium and alveolar cells.

A recent study of the single-cell transcriptome analysis found that ACE2 genes were significantly expressed in podocytes and proximal convoluted tubules as potential hosts cells targeted by SARS-CoV-2; this work suggests that the kidney might be an important target organ for SARS-CoV-2. 24 A retrospective cohort study reported that mortality was higher in COVID-19 with AKI versus COVID-19 patients without AKI (60.5% vs 27.4%), and AKI was an independent predictor of mortality. 25 Our study revealed that AKI incidence rates of 14.0% in all hospitalized patients and 61.3% in the nonsurvivors. These data provide robust evidence to support that patients with COVID-19 should be closely monitored for the development of AKI and measures taken to prevent it. This study has several limitations. First, our study was conducted in 1 hospital, thereby potentially limiting the generalizability to hospital settings, especially in terms of the demographic characteristics of the patient population and the external validation of the prediction models. Second, missing data on some variables, such as erythrocyte sedimentation rate (ESR), PCT, and cardiac troponin I, may cause bias in the estimation and reduce the representativeness of the samples. Finally, interpretation of our findings might be limited by the small sample size.

In conclusion, we found that high SOFA score, history of diabetes, and LDH greater than 245 U/L were risk factors for in-hospital death of adult patients with COVID-19. The nomogram proposed in our study objectively predicted the prognosis of patients with COVID-19.

Author Contributions. Yuanyuan Niu, Zan Zhan, and Jianfeng Li contributed equally to this work.

Conflicts of Interest. The authors declare no conflict of interests. 

World Health Organization

Clinical course and risk factors for mortality of adult in patients with COVID-19 in Wuhan, China: a retrospective cohort study

Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China

Comorbidity and its impact on 1590 patients with Covid-19 in China: a nationwide analysis

Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study

Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected: interim guidance

Clinical features of patients infected with 2019 novel coronavirus in Wuhan

Developing a new definition and assessing new clinical criteria for septic shock: for the third international consensus definitions for sepsis and septic shock

KDIGO clinical practice guidelines for acute kidney injury

Acute respiratory distress syndrome: the Berlin Definition

National Health Commission of the People's Republic of China

A prediction rule to identify low-risk patients with community-acquired pneumonia

Defining communityacquired pneumonia severity on presentation to hospital: an international derivation and validation study

The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure

APACHE||: a severity of disease classification system

Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan

Risk factors associated with clinical outcomes in 323 COVID-19 hospitalized patients in Wuhan, China

Predictive factors for disease progression in hospitalized patients with coronavirus disease 2019 in Wuhan

Characteristics of and important lessons from the coronavirus disease 2019 (Covid-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention

Early predictors of clinical deterioration in a cohort of 239 patients hospitalized for covid-19 infection in Lombardy, Italy

Profile of RT-PCR for SARS-CoV-2: a preliminary study from 56 COVID-19 patients

Factors associated with prolonged viral RNA shedding in patients with COVID-19

Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China

Identification of a potential mechanism of acute kidney injury during the COVID-19 outbreak: a study based on single-cell transcriptome analysis

Acute kidney injury associated with COVID-19: a retrospective cohort study